I am new to the company, new to SAMD, but not new to medical device regulations. The company has documented a medical device software with no EDO. I don't think the definition of EDO is aligned with FDA regulations. Here is how they define:
I feel we are missing on two points: 1) Identifying Essential Design Outputs is not limited to those that can impact safety risk, but any that can impact the proper functioning. A mechanical pencil can have essential design outputs. 2) Identifying EDOs is not "where applicable."
I have found the few pieces of information the FDA has published related to design controls and design outputs. It's not super definitive. Is there any additional published information that I can use to improve our understanding of EDO? Thanks!
Critical Component:
A component, or sub-assembly, whose failure to perform as per specification could reasonably be expected to lead to unacceptable safety risk and/or the need for corrective field action.
Critical components are considered to be the essential design outputs for the proper functioning of the device.
In the design control procedure, there is no use of the terms "Essential Design Outputs", "Design Output", "Critical Components." The Risk Management file states that the risks associated with the software are not safety risks, hence there are no Critical Components (and, by definition then, no Essential Design Outputs.) I feel we are missing on two points: 1) Identifying Essential Design Outputs is not limited to those that can impact safety risk, but any that can impact the proper functioning. A mechanical pencil can have essential design outputs. 2) Identifying EDOs is not "where applicable."
I have found the few pieces of information the FDA has published related to design controls and design outputs. It's not super definitive. Is there any additional published information that I can use to improve our understanding of EDO? Thanks!